Spasmodic Dysphonia Clinical Trial
Official title:
Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
This is a study of patients with spasmodic dysphonia to determine how best to measure the severity of the disorder in patients. It addresses which characteristics of speech are the best indicator of whether or not a particular treatment has benefited a person with spasmodic dysphonia. We hope to recruit 20 participants each at 2 different centers. The evaluation for each participant will be done on a two visits, one just before and another several weeks after treatment.
This is a study of changes in voice and laryngeal function with treatment recorded using the
Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP). Persons with adductor
spasmodic dysphonia will complete a questionnaire on the Voice Handicap Index (VHI) and
ratings of speech effort as well as have their speech recorded and receive a
nasolaryngoscopy examination prior to their usual treatment with botulinum toxin injection
into the laryngeal muscles for their voice disorder. They will return for re-examination
several weeks later after their injection and repeat each of the examinations. The purpose
is to determine which items on the SD-DAP are sensitive to changes in the severity of their
voice disorder. The items that show sensitivity would be those that would be useful for
assessing voice outcomes in clinical trials. Some of the questions this study is trying to
answer are
- What is the best way to measure the severity of spasmodic dysphonia?
- How does treatment of spasmodic dysphonia by botulinum toxin injection affect voice for
communication in regular daily life in spasmodic dysphonia
- Is change in speaking effort related to the change in severity of spasmodic dysphonia
with botulinum toxin injection?
Each participant in this study will be asked to do the following:
- Provide a copy of medical records and medical history relating to the diagnosis of
spasmodic dysphonia.
- Have an examination by an otolaryngologist with a medical periscope inserted in the
throat to view the voice box in action. The examination will be so it can be reviewed
later by several different experts.
- Complete questionnaires regarding the severity of their disorder before and after
receiving their usual treatment; an injection of botulinum toxin into the laryngeal
muscles.
- Repeat a speech recording and laryngeal examination before and after treatment
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06111027 -
Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia
|
Phase 1/Phase 2 | |
Recruiting |
NCT05158166 -
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
|
Phase 1/Phase 2 | |
Recruiting |
NCT05580302 -
Cortical Silent Period in Laryngeal Dystonia
|
||
Recruiting |
NCT05150106 -
Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
|
||
Recruiting |
NCT05216770 -
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
|
Early Phase 1 | |
Recruiting |
NCT05150093 -
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
|
N/A | |
Completed |
NCT00713414 -
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
|
||
Completed |
NCT01961297 -
Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response
|
Phase 2 | |
Completed |
NCT00118586 -
Neuropathology of Spasmodic Dysphonia
|
||
Not yet recruiting |
NCT04938154 -
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia
|
Phase 2 | |
Active, not recruiting |
NCT03292458 -
Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
|
Phase 2/Phase 3 | |
Completed |
NCT02957942 -
rTMS in Spasmodic Dysphonia
|
N/A | |
Completed |
NCT02558634 -
Thalamic Deep Brain Stimulation for Spasmodic Dysphonia- DEBUSSY Trial
|
N/A | |
Terminated |
NCT00895063 -
Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia
|
N/A | |
Completed |
NCT05158179 -
Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia
|
N/A | |
Not yet recruiting |
NCT06078527 -
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort
|
N/A | |
Enrolling by invitation |
NCT05892770 -
Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
|
Phase 1/Phase 2 | |
Completed |
NCT04648891 -
Spasmodic Dysphonia Pain
|
Phase 2/Phase 3 | |
Completed |
NCT03042962 -
Brain Networks in Dystonia
|
||
Completed |
NCT03746509 -
Laryngeal Vibration for Spasmodic Dysphonia
|
N/A |